Appeal No. 2001-2524 Page 6 Application No. 08/369,295 We find no analysis of the Wands factors by the examiner. Instead, we find only the examiner’s unsupported conclusions as to why the specification does not enable the claimed invention. According to the examiner (Answer, page 6), “any peptides of five or more amino acids may prove to be antigenic when conjugated to a carrier protein but whether such an antigen will or will not be protective is not predictive from the fact that it is antigenic since such findings are empirical … based on trial and experimentation….” In addition, with regard to the carrier portion of the antigen conjugate, the examiner finds (Answer, page 8), “the specification does not provide sufficient guidance as to which natural carriers would be effective in providing a conjugate that would be effectively immunogenic and/or immunoprotective.” The examiner, however, failed to provide a factual basis for his concerns. In the absence of a fact-based statement of a rejection based upon the relevant legal standards, the examiner has not sustained his initial burden of establishing a prima facie case of non- enablement. As set forth in In re Moore, 439 F.2d 1232, 1235, 169 USPQ 236, 238 (CCPA 1971), before issues related to the patentability of the claimed subject matter can begin to be considered, the examiner must determine what is being claimed. [T]he claims must be analyzed first in order to determine exactly what subject matter they encompass…. The first inquiry therefore is merely to determine whether the claims do, in fact, set out and circumscribe a particular area with a reasonable degree of precision and particularity. It is here where the definiteness of the language employed must bePage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 NextLast modified: November 3, 2007